Publications & Presentations in the therapeutic area :

Effect of altered AGP plasma binding on heart rate changes

Steeg T.J.v., Krekels E.H., Freijer J., Danhof M.  and Lange E.C.d., Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)), J Pharm Sci, 17: 17, 2009. [Link to publication]

Influence of plasma protein binding on pharmacodynamics

Steeg T.J.v., Boralli V.B., Krekels E.H., Slijkerman P., Freijer J., Danhof M. and Lange E.C.d., Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of beta blockers using a new mechanism-based PK-PD modelling approach, J Pharm Sci., 98(10): 3816-3828., 2009. [Link to publication]

Mechanism-based pharmacodynamic modeling of S(-)-atenolol

Steeg T.J.v., Freijer J., Danhof M.  and Lange E. C. d., Mechanism-based pharmacodynamic modeling of S(-)-atenolol: estimation of in vivo affinity for the beta1-adrenoceptor with an agonist-antagonist interaction model, J Pharmacol Exp Ther., 324(3): 1234-1242., 2008. [Link to publication]

Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling

Danhof M., Lange E.C.d, Della Pasqua O.E., Ploeger B.A. and Voskuyl R.A., Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research, Trends Pharmacol Sci., 29(4): 186-191., 2008. [Link to publication]

Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats

Steeg T.J.v., Freijer J., Danhof M. and Lange E.C.d, Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint, Br J Pharmacol, 10: 10, 2007. [Link to publication]